Sources | Names Used |
---|---|
CTRPv2 | vorinostat:navitoclax (4:1 mol/mol) |
PharmacoGx | vorinostat:navitoclax (4:1 mol/mol) |
Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | ZNF850 | CTRPv2 | pan-cancer | AAC | 0.16 | 5e-06 |
mRNA | ZNF852 | CTRPv2 | pan-cancer | AAC | 0.16 | 6e-05 |
mRNA | ZNF853 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.0009 |
mRNA | ZNF862 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.002 |
mRNA | ZNF878 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.001 |
mRNA | ZNF891 | CTRPv2 | pan-cancer | AAC | 0.16 | 4e-05 |
mRNA | ZNF91 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0003 |
mRNA | ZNF93 | CTRPv2 | pan-cancer | AAC | 0.15 | 3e-05 |
mRNA | ZSCAN12 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.001 |
mRNA | ZSCAN16 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.002 |